The success of Sildenafil initially sparked a period of growth for major pharmaceutical companies, however recent developments present a uncertain picture for investors. Lower-cost competitors are eating into revenue, https://gretaxfmy319848.howeweb.com/41821560/the-blue-pill-and-big-pharma-a-risky-investment